Lv3
290 积分 2025-01-10 加入
Efficacy and Safety of Upadacitinib for Refractory Inflammatory Bowel Disease: A Multicenter Real-World Observational Study
1个月前
已完结
The Role of Colchicine in the Treatment of Autoinflammatory Diseases
2个月前
已完结
Is 2nd JAKi treatment for UC worth the effort? A retrospective, multi-centre UK study
5个月前
已关闭
A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis
6个月前
已完结
EFFICACY AND SAFETY OF UPADACITINIB FOR ACUTE SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
6个月前
已完结
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis
7个月前
已完结
Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
7个月前
已完结
Upadacitinib is associated with better clinical and biochemical outcomes than tofacitinib in refractory, moderate-to-severe UC
7个月前
已完结
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025
7个月前
已完结
EFFICACY AND SAFETY OF UPADACITINIB FOR ACUTE SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
7个月前
已完结
皖公网安备34019202002308
